Risk management strategy to increase the safety of workers in the nanomaterials industry

Journal of Hazardous Materials

Volumn 229-230, Issue , 2012, Pages 83-93

  Ling, Min Pei ^a   Lin, Wei Chao ^b   Liu, Chia Chyuan ^b   Huang, Yi Shiao ^c   Chueh, Miao Ju ^c   Shih, Tung Sheng ^d  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^c Industrial Safety and Health Association of ROC   (Taiwan)

^d INSTITUTE OF OCCUPATIONAL SAFETY AND HEALTH   (Taiwan)

Author keywords

Cytotoxic; Dermal absorption; Nanomaterials; Risk management; Solubility

Indexed keywords

ADVERSE HEALTH EFFECTS; CONVENTIONAL MATERIALS; CYTOTOXIC; DERMAL ABSORPTION; ENGINEERED NANOMATERIALS; ENGINEERING CONTROLS; ENVIRONMENTAL MONITORING; MANUFACTURING PLANT; OCCUPATIONAL HEALTH AND SAFETY; PERSONAL PROTECTIVE EQUIPMENT; PRECAUTIONARY RISK MANAGEMENT; RISK MANAGEMENT STRATEGIES; SOLUBILITY TEST; TOXICITY DATA; WORKING ENVIRONMENT;

ACCIDENT PREVENTION; INDUSTRIAL HYGIENE; INDUSTRY; MANUFACTURE; NANOSTRUCTURED MATERIALS; OCCUPATIONAL RISKS; PROTECTIVE CLOTHING; RISK ASSESSMENT; RISK MANAGEMENT; SOLUBILITY; TOXICITY;

HUMAN RESOURCE MANAGEMENT;

MULTI WALLED NANOTUBE; NANOMATERIAL; SILVER NANOPARTICLE; ZINC OXIDE;

ABSORPTION; CONCENTRATION (COMPOSITION); ENGINEERING; ENVIRONMENTAL MONITORING; HEALTH RISK; IDENTIFICATION METHOD; MANUFACTURING; RESEARCH WORK; RISK ASSESSMENT; TOXICITY; WORKPLACE;

ARTICLE; BREATHING; BREATHING APPARATUS; CELL VIABILITY; COLLOID; CYTOTOXICITY; ECHOGRAPHY; EXPOSURE; HEALTH HAZARD; HUMAN; HUMAN CELL; LIQUID; MASK; NANOENGINEERING; OCCUPATIONAL HEALTH; OCCUPATIONAL SAFETY; PARTICLE SIZE; PROTECTIVE EQUIPMENT; RESPIRATORY SYSTEM; RISK MANAGEMENT; SKIN ABSORPTION; SOLUBILITY; STRATUM CORNEUM; VENTILATOR; WORK ENVIRONMENT; WORKPLACE;

ANIMALS; CELL LINE; CELL SURVIVAL; ENVIRONMENTAL MONITORING; HUMANS; MICE; NANOSTRUCTURES; NANOTUBES, CARBON; OCCUPATIONAL EXPOSURE; PARTICLE SIZE; RISK ASSESSMENT; SILVER; SKIN ABSORPTION; SOLUBILITY; WORKPLACE; ZINC OXIDE;

EID: 84863852164     PISSN: 03043894     EISSN: 18733336     Source Type: Journal    
DOI: 10.1016/j.jhazmat.2012.05.073     Document Type: Article

References (55)

1. ANSI - American National Standards Institute, Nanotechnology Law Report, 2008. Available at: (accessed on September 2008). http://www.nanolawreport.com/NanoLawReportSeptember2008.pdf.
2. Brouwer D. Exposure to manufactured nanoparticles in different workplaces. Toxicology 2010, 269:120-127.
3. Bergamaschi E. Occupational exposure to nanomaterials: present knowledge and future development. Nanotoxicology 2009, 3:194-201.
4. Nel A., Xia T., Madler L., Li N. Toxic potential of materials at the nanolevel. Science 2006, 311:622-627.
5. Oberdörster G., Elder A., Rinderknecht A. Nanoparticles and the brain: cause for concern. J. Nanosci. Nanotechnol. 2009, 9:4996-5007.
6. Schulte P.A., Murashov V., Zumwalde R., Kuempel E.D., Geraci C.L. Occupational exposure limits for nanomaterials: state of the art. J. Nanopart. Res. 2010, 12:1971-1987.
7. Schulte P.A., Salamanca-Buentello F. Ethical and scientific issues of nanotechnology in the workplace. Environ. Health Perspect. 2007, 115:5-12.
8. Kim S.C., Chen D.R., Qi C.L., Gelein R.M., Finkelstein J.N., Elder A., Bentley K., Oberdörster G., Pui D.Y.H. A nanoparticle dispersion method for in vitro and in vivo nanotoxicity study. Nanotoxicology 2010, 4:42-51.
9. Oller A.R., Oberdörster G. Incorporation of particle size differences between animal studies and human workplace aerosols for deriving exposure limit values. Regul. Toxicol. Pharmacol. 2010, 57:181-194.
10. Rushton E.K., Jiang J., Leonard S.S., Eberly S., Castranova V., Biswas P., Elder A., Han X.L., Gelein R., Finkelstein J., Oberdörster G. Concept of assessing nanoparticle hazards considering nanoparticle dosemetric and chemical/biological response metrics. J. Toxicol. Environ. Health Part A 2010, 73:445-461.
11. Suzuki H., Toyooka T., Ibuki Y. Simple and easy method to evaluate uptake potential of nanoparticles in mammalian cells using a flow cytometric light scatter analysis. Environ. Sci. Technol. 2007, 41:3018-3024.
12. Teeguarden J.G., Hinderliter P.M., Orr G., Thrall B.D., Pounds J.G. Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments. Toxicol. Sci. 2007, 95:300-312.
13. Handy R.D., Shaw B.J. Toxic effects of nanoparticles and nanomaterials: implications for public health, risk assessment and the public perception of nanotechnology. Health Risk Soc. 2007, 9:125-144.
14. Morgan K. Development of a preliminary framework for informing the risk analysis and risk management of nanoparticles. Risk Anal. 2005, 25:1621-1635.
15. Erdely A., Hulderman T., Salmen R., Liston A., Zeidler-Erdely P.C., Schwegler-Berry D., Castranova V., Koyama S., Kim Y.A., Endo M., Simeonova P.P. Cross-talk between lung and systemic circulation during carbon nanotube respiratory exposure, potential biomarkers. Nano Lett. 2009, 9:36-43.
16. Kandlikar M., Ramachandran G., Maynard A., Murdock B., Toscano W.A. Health risk assessment for nanoparticles: a case for using expert judgment. J. Nanopart. Res. 2007, 9:137-156.
17. J.T. Bartis, E. Landree, Nanomaterials in the workplace: policy and planning workshop on occupational safety and health, Santa Monica, CA, USA: RAND Corporation Report, 2006.
18. Maynard A.D., Kuempel E.D. Airborne nanostructured particles and occupational health. J. Nanopart. Res. 2005, 7:587-614.
19. Oberdörster G., Maynard A., Donaldson K., Castranova V., Fitzpatrick J., Ausman K., Carter J., Karn B., Kreyling W., Lai D., Olin S., Monteiro-Riviere N., Warheit D., Yang H. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part. Fibre Toxicol. 2005, 2:1-35.
20. W. Luther, Technological analysis: industrial application of nanomaterials - chances and risks, Düsseldorf, Germany: VDI Technologiezentrum Report, 2004.
21. Tsuji J.S., Maynard A.D., Howard P.C., James J.T., Lam C.W., Warheit D.B., Santamaria A.B. Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles. Toxicol. Sci. 2006, 89:42-50.
22. Crosera M., Bovenzi M., Maina G., Adami G., Zanette C., Florio C., Larese F.F. Nanoparticle dermal absorption and toxicity: a review of the literature. Int. Arch. Occup. Environ. Health 2009, 82:1043-1055.
23. Schulte P., Geraci C., Zumwalde R., Hoover M., Kuempel E. Occupational risk management of engineered nanoparticles. J. Occup. Environ. Hyg. 2008, 5:239-249.
24. Schulte P.A., Trout D., Zumwalde R.D., Kuempel E., Geraci C.L., Castranova V., Mundt D.J., Mundt K.A., Halperin W.E. Options for occupational health surveillance of workers potentially exposed to engineered nanoparticles: state of the science. J. Occup. Environ. Med. 2008, 50:517-526.
25. Schmoll L.H., Elzey S., Grassian V.H., O'Shaughnessy P.T. Nanoparticle aerosol generation methods from bulk powders for inhalation exposure studies. Nanotoxicology 2009, 3:265-275.
26. Oberdörster G., Oberdörster E., Oberdörster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 2005, 113:823-839.
27. Tinkle S.S., Antonini J.M., Rich B.A., Roberts J.R., Salmen R., DePree K. Skin as a route of exposure and sensitization in chronic beryllium disease. Environ. Health Perspect. 2003, 111:1202-1208.
28. Herzog E., Casey A., Lyng F.M., Chambers G., Byrne H.J., Davoren M. A new approach to the toxicity testing of carbon-based nanomaterials - the clonogenic assay. Toxicol. Lett. 2007, 174:49-60.
29. Monteiro-Riviere N.A., Inman A.O. Challenges for assessing carbon nanomaterial toxicity to the skin. Carbon 2006, 44:1070-1078.
30. Santhanam P., Wagner J.G., Elder A., Gelein R., Carter J.M., Driscoll K.E., Oberdörster G., Harkema J.R. Effects of subchronic inhalation exposure to carbon black nanoparticles in the nasal airways of laboratory rats. Int. J. Nanotechnol. 2008, 5:30-54.
31. Baker G.L., Gupta A., Clark M.L., Valenzuela B.R., Staska L.M., Harbo S.J., Pierce J.T., Dill J.A. Inhalation toxicity and lung toxicokinetics of C-60 fullerene nanoparticles and microparticles. Toxicol. Sci. 2008, 101:122-131.
32. Tiede K., Boxall A.B.A., Tear S.P., Lewis J., David H., Hassellov M. Detection and characterization of engineered nanoparticles in food and the environment. Food Addit. Contam. Part A: Chem. 2008, 25:795-821.
33. OECD -- Organisation for economic co-operation and development, OECD guideline for the testing of chemicals. Skin absorption: in vitro method, 2004. Available at: (accessed on April 2004). http://www.oecd-ilibrary.org/environment/test-no-428-skin-absorption-in-vitro-method_9789264071087-en.
34. WHO - World Health Organization, Draft Environmental Health Criteria (EHC): Dermal Exposure, 2010. Available at: (accessed on July 2010). http://www.who.int/ipcs/methods/dermal_exposure.pdf.
35. USEPA - U.S. Environmental Protection Agency, Risk assessment guidance for superfund, vol. I: Human Health Evaluation Manual, 2004. Available at: (accessed on July 2004) U.S. EPA/540/R/99/005. http://www.epa.gov/oswer/riskassessment/ragse/index.htm.
36. Davison Z., Nicholson R.I., Maillard J.Y., Denyer S.P., Heard C.M. Control of microbial contamination of Franz diffusion cell receptor phase in the development of transcutaneous breast cancer therapeutics. Lett. Appl. Microbiol. 2009, 49:456-460.
37. Sekkat N., Kalia Y.N., Guy R.H. Biophysical study of porcine ear skin in vitro and its comparison to human skin in vivo. J. Pharm. Sci. 2002, 91:2376-2381.
38. Kreyling W.G., Semmler M., Erbe F., Mayer P., Takenaka S., Schulz H., Oberdörster G., Ziesenis A. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J. Toxicol. Environ. Health Part A 2002, 65:1513-1530.
39. Borm P.J.A., Schins R.P.F., Albrecht C. Inhaled particles and lung cancer, part B: paradigms and risk assessment, Int. J. Cancer 2004, 110:3-14.
40. R. Tomellini, C. de Villepin, Nanotechnology, Proceedings of the Workshop: Research Needs on Nanoparticles, Brussels, European Commission, Office CDMA Report, 2005.
41. Itoh K., Pongpeerapat A., Tozuka Y., Oguchi T., Yamamoto K. Nanoparticle formation of poorly water-soluble drugs from ternary ground mixtures with PVP and SDS. Chem. Pharm. Bull. 2003, 51:171-174.
42. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
43. Reijnders L. Human health hazards of persistent inorganic and carbon nanoparticles. J. Mater. Sci. 2012, 47:5061-5073.
44. Rengasamy S., King W.P., Eimer B.C., Shaffer R.E. Filtration performance of NIOSH-approved N95 and P100 filtering facepiece respirators against 4-30nm-size nanoparticles. J. Occup. Environ. Hyg. 2008, 5:556-564.
45. Pui D.Y.H., Qi C.L., Stanley N., Oberdörster G., Maynard A. Recirculating air filtration significantly reduces exposure to airborne nanoparticles. Environ. Health Perspect. 2008, 116:863-866.
46. Luo Z.X., Wang Z.H., Wei Q.S., Yan C.Z., Liu F. Effects of engineered nano-titanium dioxide on pore surface properties and phosphorus adsorption of sediment: its environmental implications. J. Hazard. Mater. 2011, 192:1364-1369.
47. Peralta-Videa J.R., Zhao L.J., Lopez-Moreno M.L., de la Rosa G., Hong J., Gardea-Torresdey J.L. Nanomaterials and the environment: a review for the biennium 2008-2010. Environ. Health Perspect. 2011, 186:1-15.
48. Myojo T., Ogami A., Oyabu T., Morimoto Y., Hirohashi M., Murakami M., Nishi K., Kadoya C., Tanaka I. Risk assessment of airborne fine particles and nanoparticles. Adv. Powder Technol. 2010, 21:507-512.
49. Grieger K.D., Hansen S.F., Baun A. The known unknowns of nanomaterials: describing and characterizing uncertainty within environmental, health and safety risks. Nanotoxicology 2009, 3:222-233.
50. Linkov I., Satterstrom F.K., Monica J.C., Hansen S.F., Davis T.A. Nano risk governance: current developments and future perspectives. Nanotechnol. Law Business 2009, 6:203.
51. Grieger K.D., Linkov I., Hansen S.F., Baun A. Environmental risk analysis for nanomaterials: review and evaluation of frameworks. Nanotoxicology 2012, 6:196-212.
52. Giacobbe F., Monica L., Geraci D. Risk assessment model of occupational exposure to nanomaterials. Hum. Exp. Toxicol. 2009, 28:401-406.
53. Groso A., Petri-Fink A., Magrez A., Riediker M., Meyer T. Management of nanomaterials safety in research environment. Part. Fibre Toxicol. 2010, 7(40).
54. Paik S.Y., Zalk D.M., Swuste P. Application of a pilot control banding tool for risk level assessment and control of nanoparticle exposures. Ann. Occup. Hyg. 2008, 52:419-428.
55. Tervonen T., Linkov I., Figueira J.R., Steevens J., Chappell M., Merad M. Risk-based classification system of nanomaterials. J. Nanopart. Res. 2009, 11:757-766.